Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: RTOG 0834 Principal Investigator: Robinson, Clifford
Title: Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma: The Catnon Intergroup Trial
Phase: III Disease Site: Brain and Central Nervous System
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to determine whether the addition of temozolomide treatment to radiotherapy (concomitant treatment) or the addition of temozolomide treatment after completion of radiotherapy on 5 days out of every 28 days for 12 months (adjuvant treatment) will improve the results of the treatment. This study will find out what effects, good and/or bad, the addition of temozolomide has when it is given at the same time as radiotherapy, after radiotherapy, or both.
 
More Information:
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)